[go: up one dir, main page]

GB201019467D0 - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
GB201019467D0
GB201019467D0 GB201019467A GB201019467A GB201019467D0 GB 201019467 D0 GB201019467 D0 GB 201019467D0 GB 201019467 A GB201019467 A GB 201019467A GB 201019467 A GB201019467 A GB 201019467A GB 201019467 D0 GB201019467 D0 GB 201019467D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agent
rcwgessedc
qsltr
lteilkgg
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201019467A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOTECNOL INC
Original Assignee
Biotecnol SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotecnol SA filed Critical Biotecnol SA
Priority to GB201019467A priority Critical patent/GB201019467D0/en
Publication of GB201019467D0 publication Critical patent/GB201019467D0/en
Priority to PCT/GB2011/001620 priority patent/WO2012066293A1/en
Ceased legal-status Critical Current

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides a polypeptide consisting essentially of the amino acid sequence LTEILKGG VLIQRNPQLC YQDTILWKDI FHKNNQLALT LIDTNRSRAC HPCSPMCKGS RCWGESSEDC QSLTR (SEQ ID NO:1) or a fragment thereof.
GB201019467A 2010-11-17 2010-11-17 Therapeutic agent Ceased GB201019467D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201019467A GB201019467D0 (en) 2010-11-17 2010-11-17 Therapeutic agent
PCT/GB2011/001620 WO2012066293A1 (en) 2010-11-17 2011-11-17 Therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201019467A GB201019467D0 (en) 2010-11-17 2010-11-17 Therapeutic agent

Publications (1)

Publication Number Publication Date
GB201019467D0 true GB201019467D0 (en) 2010-12-29

Family

ID=43431586

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201019467A Ceased GB201019467D0 (en) 2010-11-17 2010-11-17 Therapeutic agent

Country Status (2)

Country Link
GB (1) GB201019467D0 (en)
WO (1) WO2012066293A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3297658A1 (en) * 2015-05-18 2018-03-28 OncoQR ML GmbH Her2/neu immunogenic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
WO1993012227A1 (en) 1991-12-17 1993-06-24 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
EP1246597B1 (en) * 1999-08-03 2015-01-14 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
JP4284490B2 (en) * 2001-07-16 2009-06-24 大塚製薬株式会社 erbB-2 related peptides
US6960657B2 (en) 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
PE20070207A1 (en) * 2005-07-22 2007-03-09 Genentech Inc COMBINED TREATMENT OF TUMORS THAT EXPRESS HER

Also Published As

Publication number Publication date
WO2012066293A1 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
NZ596658A (en) Dig-10 insecticidal cry toxins
UA118167C2 (en) Peptides and their use
MX340014B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX2012008998A (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX2012009000A (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX340016B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
IN2014CN04498A (en)
IN2014KN01715A (en)
NZ600731A (en) Oxyntomodulin peptide analogue
MX393988B (en) Interferon î±2b variants
NZ630536A (en) Therapeutic agent or prophylactic agent for dementia
MX2012001346A (en) Modified factor ix polypeptides and uses thereof.
PH12013500714A1 (en) Anticancer fusion protein
WO2010129895A3 (en) Cd133 epitopes
NZ594480A (en) Methods and compositions for diagnosis and treatment of cancer
UA100127C2 (en) Peptide cdh3 and drug containing it
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
PH12013500715A1 (en) Anticancer fusion protein
JP2010265269A5 (en)
MY193807A (en) T-cell receptor and uses thereof
IN2014DN09367A (en)
MX2011013972A (en) Novel peptide and use thereof.
EP2552462A4 (en) CCN3 PEPTIDES AND ANALOGS THEREOF FOR THERAPEUTIC USE
SG195302A1 (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same
MX2010005816A (en) Stat3 epitope peptides.

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: BIOTECNOL INC

Free format text: FORMER OWNER: BIOTECNOL S.A.

AT Applications terminated before publication under section 16(1)